Aftab Alam

Aftab Alam

Auto-generated profile, based on publicly available information

Aftab Alam

Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2010 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
PDF file
MAMohd Sarfaraz Alam
Mohd Sarfaraz Alam
MAMohd Aftab Alam
Mohd Aftab Alam
SASayeed Ahmad
Sayeed Ahmad
ANAbul Kalam Najmi
Abul Kalam Najmi
MAMOHD ASIF
MOHD ASIF
TJTamanna Jahangir
Tamanna Jahangir
In the present investigation standardized aqueous methanolic extract of Punica (AMP) was used for its possible ulcer protective activity in wistar rats against different experimental models. Preliminary phytochemical screening of AMP reveals the presence of saponin, tannins, and flavonoids, which may be responsible for its activity. HPTLC finger prints of AMP showed the presence of 12 spots at different (retention factor) rf values. Oral administration of AMP (490 and 980 mg/kg bw) significantly reduced the ulcer lesion index produced by alcohol, indomethacin, and aspirin, at both doses in rats. Further, in pylorus-ligated rats AMP significantly reduces the ulcer lesions, gastric volume, and total acidity. It prevents the ulceration by increasing the pH and mucus secretion in pylorus ligated rats. The present study shows the anti-ulcer activity of AMP in experimentally-induced gastric ulcers.

6 October 2017 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
RARaquib Alam
Raquib Alam
AAAftab Alam
Aftab Alam
APAmulya K. Panda
Amulya K. Panda
RRRahis Rahisuddin
Rahis Rahisuddin

1 October 2021 in The Natural Products Journal
Verified
Journal Article
Closed access
PDF file
RKRizwana Khatoon
Rizwana Khatoon
AAAftab Alam
Aftab Alam
PSPramod Kumar Sharma
Pramod Kumar Sharma
Aim: The purpose of this review paper is to elaborate many nano-formulations of Rosemary which are used against many diseases and also explain the Pharmacological activity of phytocompounds of Rosemary and details about the applications and uses of Rosemary in many fields. Objectives: Rosemary (Rosmarinus officinalis L.) is a medicinal herbal plant, their leaves are used in Europe, America, and Asia as a food additive. It is very valuable, their parts contain many chemical constituents which are very effective against many diseases like diabetes, obesity, cancer, infections and also have antioxidant, anti-inflammation, memory-improvement, etc. properties. Results: In the literature reviewed, Rosmarinus officinalis (rosemary) has shown exciting potential both as a natural food preservative and as a therapeutic agent. Rosemary (Rosmarinus officinalis) essential oil has been extensively studied due to its chemical composition and biological activities. The extract of Rosemary also shows the medicinal properties like anticancer, antimicrobial, antidiabetic, anti-inflammatory etc. From many studies, it was also found that nano-formulation of Rosemary had been developed by using the Rosemary essential oil and its extract which are used in the diagnosis and treatment of many diseases. Conclusion: From the conventional times, therapeutic effects of Rosemary are seen, which is also used in Modern Medicine now days. It had been used as food additives in the conventional times. In renal colic and dysmenorrhea, it is used as an antispasmodic to relieve respiratory disorders and to boost hair development. CNS, cardiac and locomotive activity promotes inhalation and oral administration of Rosemary oil, suggesting the direct effect of one or more of its constituents. Rosemary have curative potential in the therapy and avoidance of bronchial asthma, peptic ulcer, spasmodic disorders, inflammatory illnesses, atherosclerosis, hepatotoxicity, cancer, ischemic heart illness, bad sperm motility, Alzheimer, and may act as antidepressant and anxiolytic properties.

1 August 2024 in Recent Advances in Anti-Infective Drug Discovery
Verified
Journal Article
Closed access
PDF file
AYAgrima Yadav
Agrima Yadav
SYShikha Yadav
Shikha Yadav
AAAftab Alam
Aftab Alam
Lymphatic filariasis is an infection caused by parasites that poses a significant health, social, and economic burden, affecting a vast population that exceeds 120 million individuals globally. The Etiology of the infection is attributed to three nematode parasites, namely Wuchereria bancrofti, B. timori, and Brugia malayi, as well as which are phylogenetically related. These parasites are transmitted to humans via mosquitoes belonging to the Anopheles, Aedes genera, and Culex. As per the estimation provided by the WHO, the current number of individuals infected with filariasis stands at approximately 120 million across 81 countries. Furthermore, it is estimated that around 1.34 billion individuals reside in regions that are endemic to filariasis, thereby putting them at risk of contracting the disease. Different synthetic drugs such as Ivermectin, Doxycycline, Albendazole, and Suramin are used in the treatment. Some natural plants are Azadirachta indica, Tinospora cordifolia, Zingiber officinal, as well as, some marine sources are also included for better treatment. We also touch briefly on a few additional filarial diseases. Although there are only a few medications available to treat filariasis, their frequent usage may result in drug resistance. Furthermore, there is no effective vaccination for the treatment of filariasis. Due to these restrictions, it has been crucial to create new anti-filarial medications, which motivates researchers to find novel pharmaceuticals with anti-filarial action. In this article, we examine the latest achievements in the anti-filarial area, including the many forms of filariasis and their historical contexts, elimination programmes, various therapeutic classes (both synthetic and natural), investigated product-derived targets as well as clinical investigations.

13 March 2021 in Oral Science International
Verified
Journal Article
Closed access
PDF file
NTNeeraj Taneja
Neeraj Taneja
AAAftab Alam
Aftab Alam
RPRanjana S. Patnaik
Ranjana S. Patnaik
TTTannu Taneja
Tannu Taneja

1 October 2024 in Current Traditional Medicine
Verified
Journal Article
Closed access
PDF file
SSSumbul Shadab
Sumbul Shadab
GRGSN Koteswara Rao
GSN Koteswara Rao
DPDeepika Paliwal
Deepika Paliwal
DYDevdhar Yadav
Devdhar Yadav
AAAftab Alam
Aftab Alam
JSJaha Sultana
Jaha Sultana
The choices of treatment for Alzheimer's are based on NMDA-receptor antagonists and cholinesterase inhibitors, although their efficacy as a therapy is still up for debate. BPSD (Behavioural and Psychological Symptoms of Dementia) have been treated using herbal medicine products, with varying degrees of success. This manuscript sets out to answer the question, "Can herbs be effective in the treatment of cognitive impairments in patients?" by examining evidences from controlled research. The process by which Alzheimer's disease develops remains a mystery, and the present Alzheimer's treatment strategy, which consists of administering a single medicine to treat a single target, appears to be clinically ineffective. AD treatment will require a combination of approaches that target many signs and causes of the disease. The results of currently available licensed therapies for AD are often disappointing, and alternative medicine, especially herbal therapy, may play a role. Over 80% of the world's population, particularly in developing nation, gets their main health care from herbal medicines. They have persisted through the years due to their low risk, high reward, widespread acceptance across cultures, and absence of detrimental side effects. In some cases, herbal remedies have proven to be more effective than conventional medical treatments. They are assumed to be natural unless proven otherwise by the presence of unnatural additives. The absence of adverse reactions is a major advantage of herbal treatment. In addition, they provide ongoing advantages to health. Salvia officinalis, Ginkgo biloba, Melissa officinalis, Panax ginseng, Coriandrum sativum, Curcuma longa, Ashwagandha, Uncaria Tomentosa, Crocus Sativus and Allium Sativum are all studied for their potential effects on Alzheimer's disease.